Chlorthalidone
Chlorthalidone is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Chlorthalidone; Generic name: CHLORTHALIDONE; Drug class: Thiazide-like Diuretic [EPC].
| Brand name | Chlorthalidone |
|---|---|
| Generic name | CHLORTHALIDONE |
| Drug class | Thiazide-like Diuretic [EPC] |
| Manufacturer | Bryant Ranch Prepack |
| Used for | INDICATIONS & USAGE Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Usage in Pregnancy The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to |
| Dosage | DOSAGE & ADMINISTRATION Therapy should be initiated with the lowest possible dose. This dose should be titrated according to individual patient response to gain maximal therapeutic benefit while maintaining lowest dosage possible. A single dose given in the morning with food is recommended; divided daily doses are unnecessary. Hypertension Initiation: Therapy, in most patients, should be initiated with a single daily dose of 25 mg. If the response is insufficient after a suitable trial, the dosa |
| Warnings | WARNINGS Chlorthalidone should be used with caution in severe renal disease. In patients with renal disease, chlorthalidone or related drugs may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function. Chlorthalidone should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma. Sensitivity reactions may occur in patients w |
| Active ingredient(s) | CHLORTHALIDONE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=165e5993-eb9d-4664-97dc-574ae5e0e946 |